首页> 外文期刊>Journal of Drug Delivery and Therapeutics >An integrative review of Cisplatin: the first metal Anti-Tumor drug.
【24h】

An integrative review of Cisplatin: the first metal Anti-Tumor drug.

机译:顺铂的综合综述:第一种金属抗肿瘤药物。

获取原文
           

摘要

Cisplatin and other platinum derivatives like carboplatin and oxaliplatin are widely used chemotherapeutic agents used in the treatment of solid tumors including head and neck, ovarian and testicular germ cell tumors. Cisplatin is also used successfully in the treatment of paediatric malignancies, such as medulloblastoma and osteogenic sarcoma. In most recent treatment schedules, the drug is used in combination with other cytotoxic agents such as otoposide, doxorubicine, paclitaxel, 5-fluorouracil, gemcitabine, vinblastine, bleomycin and others. It is one of on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in health system. This comprehensive review highlights the physicochemical properties of cisplatin and related platinum based drugs, uses of platinum, either alone or in combination with other drugs for the treatment of various human cancers and also discuss about various Potential protective strategies against cisplatin-induced cytotoxicities. A special attention is given to it’s molecular mechanisms of action, historical background, undesirable side effects & future prospective.
机译:顺铂和其他铂衍生物(如卡铂和奥沙利铂)是广泛用于实体瘤(包括头颈部,卵巢和睾丸生殖细胞肿瘤)治疗的化学治疗剂。顺铂还成功用于治疗小儿恶性肿瘤,例如髓母细胞瘤和成骨肉瘤。在最新的治疗方案中,该药物与其他细胞毒性剂(如otoposide,阿霉素,紫杉醇,5-氟尿嘧啶,吉西他滨,长春碱,博来霉素等)联合使用。它是世界卫生组织《基本药物清单》中的一种,它是卫生系统中所需的最有效和最安全的药物。这篇全面的综述着重介绍了顺铂和相关铂基药物的理化特性,以及铂单独或与其他药物联合用于治疗各种人类癌症的用途,还讨论了针对顺铂诱导的细胞毒性的各种潜在保护策略。特别要注意的是其分子作用机理,历史背景,不良副作用和未来前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号